David D. Chang - 14 Mar 2024 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Signature
/s/Earl Douglas, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
14 Mar 2024
Transactions value $
-$231,192
Form type
4
Filing time
18 Mar 2024, 20:10:36 UTC
Previous filing
31 Jan 2024
Next filing
20 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Tax liability -$231K -53.4K -1.18% $4.33 4.47M 14 Mar 2024 Direct F1, F2, F3
holding ALLO Common Stock 1.2M 14 Mar 2024 See footnote F4
holding ALLO Common Stock 856K 14 Mar 2024 See footnote F5
holding ALLO Common Stock 856K 14 Mar 2024 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Includes 5,468 shares of the Issuer's common stock acquired by the reporting person on March 15, 2024 pursuant to an employee stock purchase program.
F4 Securities held in the name of the Chang 2006 Family Trust
F5 Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
F6 Securities held in the name of the RTC 2019 Trust dated October 1, 2019.